Stevanato Group/$STVN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Stevanato Group
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
Ticker
$STVN
Sector
Primary listing
NYSE
Industry
Life Sciences Tools and Services
Headquarters
Piombino Dese, Italy
Employees
5,521
Website
Stevanato Group Metrics
BasicAdvanced
$6.7B
47.14
$0.52
0.55
$0.06
0.22%
Price and volume
Market cap
$6.7B
Beta
0.55
52-week high
$28.00
52-week low
$17.12
Average daily volume
318K
Dividend rate
$0.06
Financial strength
Current ratio
1.823
Quick ratio
1.248
Long term debt to equity
22.143
Total debt to equity
27.989
Dividend payout ratio (TTM)
11.52%
Interest coverage (TTM)
26.08%
Profitability
EBITDA (TTM)
279.44
Gross margin (TTM)
27.86%
Net profit margin (TTM)
11.16%
Operating margin (TTM)
15.84%
Effective tax rate (TTM)
26.06%
Revenue per employee (TTM)
$228,350
Management effectiveness
Return on assets (TTM)
4.91%
Return on equity (TTM)
9.14%
Valuation
Price to earnings (TTM)
47.145
Price to revenue (TTM)
5.251
Price to book
4.76
Price to tangible book (TTM)
5.06
Price to free cash flow (TTM)
-59.879
Free cash flow yield (TTM)
-1.67%
Free cash flow per share (TTM)
-0.413
Dividend yield (TTM)
0.25%
Forward dividend yield
0.22%
Growth
Revenue change (TTM)
3.81%
Earnings per share change (TTM)
-9.91%
3-year revenue growth (CAGR)
9.22%
3-year earnings per share growth (CAGR)
-1.51%
3-year dividend per share growth (CAGR)
1.92%
What the Analysts think about Stevanato Group
Analyst ratings (Buy, Hold, Sell) for Stevanato Group stock.
Bulls say / Bears say
Stevanato Group reported a 10% revenue growth in fiscal year 2023, reaching €1.1 billion, driven by increased demand for high-value solutions. (BioSpace)
The company secured a 44% increase in new order intake in Q4 2023, totaling approximately €342 million, indicating strong future demand. (Stevanato Group Investor Relations)
Stevanato Group's strategic investments in capacity expansion for high-value solutions position it to capitalize on growing demand in the biologics sector. (BioSpace)
The company's gross profit margin decreased to 27.4% in fiscal year 2024, down from 31.3% in 2023, due to lower vial volumes and start-up inefficiencies. (BioSpace)
Stevanato Group reported negative free cash flow of €76.0 million in Q4 2023, primarily due to high capital expenditures for capacity expansion. (Stevanato Group Investor Relations)
The Engineering Segment experienced a 16% revenue decline in Q4 2024, reflecting challenges in project execution and market demand. (BioSpace)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
Stevanato Group Financial Performance
Revenues and expenses
Stevanato Group Earnings Performance
Company profitability
Stevanato Group News
AllArticlesVideos
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.
Business Wire·1 week ago
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025
Business Wire·1 week ago
Stevanato Group to Participate in Upcoming Investor Conferences
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Stevanato Group stock?
Stevanato Group (STVN) has a market cap of $6.7B as of August 01, 2025.
What is the P/E ratio for Stevanato Group stock?
The price to earnings (P/E) ratio for Stevanato Group (STVN) stock is 47.14 as of August 01, 2025.
Does Stevanato Group stock pay dividends?
Yes, the Stevanato Group (STVN) stock pays dividends to shareholders. As of August 01, 2025, the dividend rate is $0.06263 and the yield is 0.22%. Stevanato Group has a payout ratio of 11.52% on a trailing twelve-month basis.
When is the next Stevanato Group dividend payment date?
The next Stevanato Group (STVN) dividend payment date is unconfirmed.
What is the beta indicator for Stevanato Group?
Stevanato Group (STVN) has a beta rating of 0.55. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.